| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/03/2023 | 21.33% | RBC Capital | $11 → $13 | Maintains | Outperform |
| 08/10/2023 | -16.01% | Citigroup | $8 → $9 | Maintains | Neutral |
| 08/04/2023 | 2.66% | RBC Capital | $10 → $11 | Maintains | Outperform |
| 07/11/2023 | -25.34% | Citigroup | → $8 | Reiterates | Neutral → Neutral |
| 05/10/2023 | 2.66% | Mizuho | $14 → $11 | Maintains | Buy |
| 03/08/2023 | 11.99% | Deutsche Bank | $13 → $12 | Maintains | Buy |
| 03/08/2023 | 30.66% | RBC Capital | → $14 | Reiterates | → Outperform |
| 03/08/2023 | 30.66% | Mizuho | $16 → $14 | Maintains | Buy |
| 03/08/2023 | -6.67% | Citigroup | $12 → $10 | Maintains | Neutral |
| 11/14/2022 | 11.99% | Goldman Sachs | $10.5 → $12 | Maintains | Neutral |
| 11/10/2022 | 21.33% | Citigroup | $9 → $13 | Maintains | Neutral |
| 11/09/2022 | 39.99% | RBC Capital | $13 → $15 | Maintains | Outperform |
| 10/24/2022 | 21.33% | Deutsche Bank | $14 → $13 | Maintains | Buy |
| 10/18/2022 | -2.01% | Goldman Sachs | $12 → $10.5 | Maintains | Neutral |
| 10/11/2022 | -16.01% | Citigroup | $12 → $9 | Maintains | Neutral |
| 08/08/2022 | 30.66% | RBC Capital | $13 → $14 | Maintains | Outperform |
| 05/06/2022 | 21.33% | RBC Capital | $9 → $13 | Upgrades | Sector Perform → Outperform |
| 04/14/2022 | 21.33% | B of A Securities | → $13 | Downgrades | Buy → Neutral |
| 02/25/2022 | 11.99% | Deutsche Bank | $15 → $12 | Maintains | Buy |
| 12/20/2021 | 39.99% | Deutsche Bank | $17 → $15 | Upgrades | Hold → Buy |
| 11/05/2021 | 21.33% | RBC Capital | $12 → $13 | Maintains | Sector Perform |
| 10/13/2021 | 49.32% | Mizuho | → $16 | Initiates Coverage On | → Buy |
| 09/30/2021 | 49.32% | BMO Capital | → $16 | Upgrades | Market Perform → Outperform |
| 09/09/2021 | 11.99% | RBC Capital | $14 → $12 | Maintains | Sector Perform |
| 09/01/2021 | 39.99% | Goldman Sachs | → $15 | Initiates Coverage On | → Neutral |
| 08/09/2021 | 77.32% | Citigroup | $18 → $19 | Maintains | Buy |
| 03/12/2021 | 49.32% | B of A Securities | $17 → $16 | Downgrades | Neutral → Underperform |
| 03/01/2021 | 30.66% | RBC Capital | $17 → $14 | Downgrades | Outperform → Sector Perform |
| 01/20/2021 | — | Deutsche Bank | Downgrades | Buy → Hold | |
| 01/04/2021 | 77.32% | Baird | → $19 | Downgrades | Outperform → Neutral |
| 12/15/2020 | 67.99% | BMO Capital | → $18 | Downgrades | Outperform → Market Perform |
| 10/12/2020 | 58.66% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 10/12/2020 | 58.66% | BMO Capital | → $17 | Initiates Coverage On | → Outperform |
What is the target price for Pactiv Evergreen (PTVE)?
The latest price target for Pactiv Evergreen (NASDAQ: PTVE) was reported by RBC Capital on November 3, 2023. The analyst firm set a price target for $13.00 expecting PTVE to rise to within 12 months (a possible 21.33% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pactiv Evergreen (PTVE)?
The latest analyst rating for Pactiv Evergreen (NASDAQ: PTVE) was provided by RBC Capital, and Pactiv Evergreen maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Pactiv Evergreen (PTVE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pactiv Evergreen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pactiv Evergreen was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
Is the Analyst Rating Pactiv Evergreen (PTVE) correct?
While ratings are subjective and will change, the latest Pactiv Evergreen (PTVE) rating was a maintained with a price target of $11.00 to $13.00. The current price Pactiv Evergreen (PTVE) is trading at is $10.72, which is out of the analyst's predicted range.